Jamaloodeen Ahmed's Form 4 filing
ProText Mobility, Inc. (TXTM) · filed May 1, 2026
- Accession no.
- 0001140361-26-018438
- Filed
- May 1, 2026, 9:45 AM ET
- Trade date
- Jun 3, 2022-Apr 7, 2026
- Filing delay
- 1,428 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. It was filed 1428 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jamaloodeen AhmedCIK 0002131747 | Officer (Chairman and President), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2022 | Series D Preferred Stock | AGrant or awardAcquired | +66,667 | $0.001 | +$66.67 | 66,667 | Direct | Duplicate filing |
| Jun 3, 2022 | Series A Preferred Stock | AGrant or awardAcquired | +33,333 | $0.001 | +$33.33 | 33,333 | Direct | Duplicate filing |
| Dec 31, 2024 | Common Stock | PPurchaseAcquired | +89,866,874 | –F1 | – | 202,366,874 | Direct | |
| Sep 30, 2025 | Common Stock | PPurchaseAcquired | +7,170,075 | –F1 | – | 209,536,949 | Direct | |
| Apr 7, 2026 | Common Stock | PPurchaseAcquired | +45,212,287 | –F1 | – | 254,749,236 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2022 | Series D Convertible Preferred Stock | AGrant or awardAcquired | +66,667 | $0.001 | +$66.67 | 66,667 | Direct | Duplicate filing |
| Jun 3, 2022 | Series A Convertible Preferred Stock | AGrant or awardAcquired | +33,333 | $0.001 | +$33.33 | 33,333 | Direct | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Open-Ended Discretionary Stock Purchase Program. Dr. Ahmed Jamaloodeen (Chairman and President), in his private capacity and with consent of additional shareholders, has implemented an open-ended, discretionary stock purchase program. All shares reported in Table I represent open-market purchases under this ongoing program. Transaction dates reflect reporting period end dates. Actual purchases were made at prevailing market prices on the OTC Markets throughout each period. Cumulative totals: 89,866,874 shares as of 12/31/2024; 97,036,949 shares as of 09/30/2025; 142,249,236 shares as of 04/07/2026. The program is ongoing. The "Shares Owned Following Transaction" column reflects total beneficial ownership of Common Stock, including 112,500,000 shares acquired in a separate private sale transaction during 2024 which is not the subject of this filing.
Referenced by the price of 3 transactions in Table I.
Remarks
Voluntary Filing. This Form 4 is being filed voluntarily in the interest of transparency, good corporate governance, and as part of the Company's ongoing efforts to align its disclosure practices with SEC reporting standards. ProText Mobility, Inc. (TXTM) currently trades on OTC Markets under the Alternative Reporting Standard. This filing is presented in a historical context as a supplemental disclosure intended to complete the public record. Reporting Person. Dr. Ahmed Jamaloodeen serves as Chairman of the Board and President of ProText Mobility, Inc. He is a co-founder and principal of RSAMMD Acquisitions LLC, which acquired control of the Company on June 3, 2022 via share exchange. Dr. Jamaloodeen is based in Newcastle, KwaZulu-Natal, South Africa. In addition to the Common Stock reported in Table I, Dr. Jamaloodeen beneficially owns 66,667 shares of Series D Convertible Preferred Stock (66.7% of class) and 33,333 shares of Series A Convertible Preferred Stock (44.4% of class), both acquired on 06/03/2022. No conversion of Series A or Series D shares has occurred as of the date of this filing. The Reporting Person has filed Exhibit 99.1 hereto, setting forth a Summary of Beneficial Ownership as of April 7, 2026, including share counts, percentage of class (undiluted), ownership form, and source of acquisition for each class of security beneficially owned. Exhibit 99.1 is incorporated herein by reference.